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A B S T R A C T
Cerebral vein thrombosis (CVT) is a rare presentation of venous thromboembolism. Prompt and accurate di-
agnosis is essential as delayed recognition and treatment may lead to permanent disability or even death. Since
no validated diagnostic algorithms exist, the diagnosis of CVT mainly relies on neuroimaging. Digital subtraction
angiography (DSA) is the historical diagnostic standard for CVT, but is rarely used nowadays and replaced by
computed tomography (CT) and magnetic resonance imaging (MRI). High quality studies to evaluate the di-
agnostic test characteristics of state of the art imaging modalities are however unavailable to date. This review
provides an overview of the best available evidence regarding the diagnostic performance of CT and MRI for the
diagnosis of CVT. Notably, available studies are observational, mostly small, outdated, and with a high risk of
bias. Therefore, direct comparison between studies is difficult due to large diversity in study design, imaging
method, reference standard, patient selection and sample size. In general, contrast-enhanced techniques are
more accurate for the diagnosis of CVT then non-contrast-enhanced techniques. CT venography and MRI have
been both reported to be adequate for establishing a final diagnosis of CVT, but choice of modality as used in
clinical practice depends on availability, local preference and experience, as well as patient characteristics. Our
review underlines the need for high-quality diagnostic studies comparing CT venography and MRI in specific
settings, to improve clinical care and standardize clinical trials.
1. Introduction
Cerebral vein thrombosis (CVT) refers to dural sinus as well as
cerebral vein (cortical and deep vein) thrombosis, and is a rare but
potentially life threatening presentation of venous thromboembolism
[1]. It accounts for 0.5–1% of all strokes in the adult population with an
incidence of 1.32 per 100,000 person-years [2,3]. The clinical pre-
sentation of CVT is highly variable and nonspecific. Since there are no
validated diagnostic algorithms incorporating decision rules or D-dimer
tests, the diagnosis of CVT mainly relies on neuroimaging [2,4]. Neu-
roimaging is also the main method for evaluation of CVT related
complications relevant for prognosis and therapeutic management
[2,5]. Therefore, knowledge of the diagnostic performance of available
imaging modalities is of great importance for optimal management of
the individual patient.
Different imaging modalities and techniques can be used for the
diagnosis of CVT in adults. Digital subtraction angiography (DSA) once
was the diagnostic standard for CVT but is rarely used nowadays due to
its invasive nature which harbours a small risk for serious complica-
tions, including neurologic complications (i.e. neurologic sign or
symptom or worsening of a preexisting neurologic deficit that occurred
during the procedure or within 24 h) [6,7]. Neurologic complications
are reported to occur in around 1.3% of patients undergoing DSA; with
permanent deficits in 0.5% of patients [7]. Additional disadvantages of
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DSA include radiation exposure, and allergic or nephrotoxic effects of
iodinated contrast agents [8]. In current clinical practice, DSA is re-
served for exceptional cases, often when reperfusion therapy (such as
thrombosuction) is considered [4,9]. Computed tomography (CT)/CT
venography and magnetic resonance imaging (MRI) are presently the
first line tests used in clinical practice [5,10–12], but each modality and
technique has its advantages and disadvantages [13]. Randomized
controlled diagnostic trials comparing these imaging modalities are
absent, probably because of the low incidence of the disease. Therefore,
knowledge of the diagnostic performance of each of these modalities is
based on small observational studies. Results on diagnostic accuracy of
the different imaging modalities from available studies must be inter-
preted with caution and cannot directly be compared nor translated
into daily clinical practice, due to heterogeneity in study design, patient
population (clinical presentation), imaging methods and used reference
standard. Consequently, the diagnostic approach for the diagnosis of
CVT differs considerably per country and even per hospital [5].
We aimed to provide an overview of published literature and ap-
plied extensive literature searches to identify all relevant papers re-
garding the diagnostic performance of CT/CT venography and MRI for
the diagnosis of CVT (search strategy detailed in Appendix 1). Papers
were chosen if written in Dutch or English and evaluating the diag-
nostic accuracy of CT/CT venography and MRI in cerebral vein
thrombosis. We only excluded case-reports and reviews. Notably, in
previous publications various terminologies have been used for CVT. In
this review isolated thrombosis of the dural sinuses is referred to as
cerebral sinus thrombosis and thrombosis of both dural sinus and cer-
ebral veins as CVT.
2. Computed tomography
In the emergency setting, CT is often the imaging test of choice for
patients presenting with acute focal neurological symptoms [5,10],
since it's widely available, cost-effective and useful to rule out common
neurological diagnoses [14]. CVT may present variable on CT (Table 1).
A direct sign of CVT on non-contrast CT (NCCT) is direct visualization
of a thrombus which is predominantly caused by the protein factor of
haemoglobin within red blood cells, often called the “dense clot sign” or
“dense vessel sign” (Fig. 1A) [15]. After the administration of a contrast
agent the thrombus can directly be visualized as a filling defect within a
dural sinus also called “empty delta sign”, which is specific for
thrombosis of the superior sagittal sinus [2,9]. On CT indirect signs of
CVT are often seen and may occur in 60–80% of cases [14]. Common
indirect signs on CT that are highly evocative of CVT are multiple bi-
lateral lesions (e.g. bilateral parasagittal hemispheric lesions are sug-
gestive of superior sagittal sinus thrombosis), bilateral thalamic edema
(can be found in deep cerebral vein thrombosis) and temporo-occipital
lesions (suggestive for transverse sinus thrombosis) [14,16,17]. Cere-
bral haemorrhage is also a common finding in patients with CVT,
present in approximately 40% of patients [18]. Juxtacortical hemor-
rhages, small hemorrhages with limited or no edema, localized at the
junction between the superficial and deep venous drainage system, are
seen in up to 12% of CVT patients and are very specific for CVT and
almost exclusively occur in superior sagittal sinus thrombosis [18].
There are several studies that evaluated the diagnostic accuracy of
direct and indirect signs on NCCT. These studies (with sample sizes
ranging between 7 and 588 patients), which were all retrospective,
mostly small and using different reference standards (CT venography,
MRI, DSA and/or multiple imaging and follow up), found a sensitivity
of 41–100% and specificity of 77–100% (Appendix 2) [19–26,90]. The
best reported diagnostic accuracy of the attenuated vein sign on NCCT
for the diagnosis of deep cerebral vein thrombosis was a sensitivity of
100% and specificity of 99% [20]. It is important to note that this was
found in a small single center retrospective study, including only 8
patients diagnosed with deep cerebral vein thrombosis [20]. The re-
ported accuracy for cerebral sinus thrombosis is a sensitivity of
50–100% and a specificity of 83–100% [20–22,24,25]. An explanation
for these wide ranges may be the different scan technologies and ac-
quisition measures used, with a generally lower sensitivity in older
studies [23]. Poor interrater variability of the evaluation of direct and
indirect signs on NCCT may also play a role [26]. In the specific setting
of isolated cortical vein thrombosis, the reported sensitivity and spe-
cificity are 25% (95%CI 18–25%) and 100% (95%CI 92–100%), re-
spectively [21]. In these studies, a thrombus was often missed since the
“cord sign” or “string sign”, a direct sign of cortical vein thrombosis on
CT, is difficult to detect due to its location next to the skull [21].
Because of the linear association between the attenuation of blood
and haematocrit levels [27], high haematocrit values can result in a
false positive CVT diagnosis [15]. On the other hand anaemia may re-
sult in false negative diagnosis. Moreover, subacute thrombosis may
also result in false negative diagnoses since the density of thrombi at-
tenuated over time and becomes isodense or even hypodense after ap-
proximately 7–14 days [15,28]. Therefore, studies have evaluated
whether quantitative assessment of the attenuation and attenuation
values compared to haematocrit (H:H ratio) improved the diagnostic
accuracy of NCCT for the diagnosis of CVT, but did not find superior
sensitivity (64–95%) or superior specificity (54–100%)
[13,15,24–26,29–31]. Notably, after the administration of a contrast
agent, direct/indirect signs on CT scan can still be absent in up to 30%
of the CVT cases (Appendix 2) [9,32–38].
Recently, a meta-analysis summarizing the diagnostic accuracy of
CT (non-contrast- and contrast-enhanced) for CVT has been published
[39]. Twenty-four eligible publications, including 48 studies with
varying study designs and diagnostic standards were included, for a
total of 4595 individual patients. Overall, CT was found to have a
reasonable diagnostic accuracy with a pooled sensitivity of 79% (95%CI
76–82%) and a pooled specificity of 90% (95%CI 89%–91%). For the
diagnosis of cerebral sinus thrombosis, the pooled sensitivity and spe-
cificity of CT were 81% (95%CI 78–84%) and 89% (95%CI 88–91%),
respectively. Subgroup analyses showed no significant difference of the
diagnostic accuracy in suspected acute, sub-acute or chronic CVT. The
authors also found that visual assessment (evaluation of direct/indirect
signs) was more accurate than quantitative assessment (attenuation
evaluation) [39].
In summary, while CT is useful as primary imaging modality in
patients with suspected acute CVT, additional imaging is generally re-
quired to diagnose and rule out CVT with more certainty
[2,5,15,26,40].
Table 1
(Non-)contrast-enhanced computed tomography (CT) findings in cerebral vein thrombosis.
Direct signs Indirect signs
Non-contrast CT (NCCT) • Dense clot sign: direct visualization of the thrombus in the cerebral sinus and veins• Cord or string sign (dense vessel sign): linear or cord-like density of a thrombosed
cortical vein
• Haemorrhagic infarction• Brain oedema• Mass effect• Subarachnoid haemorrhage
Contrast-enhanced CT (CECT) • Empty delta sign: thrombosed sinus seen as triangular area of enhancement with
relatively low-attenuation center
• Same findings as on NCCT
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3. CT venography
CT venography is one of the most often used imaging modalities for
the diagnosis of CVT because of its widespread availability and cost-
effectiveness [5]. CT venography is a contrast-enhanced helical CT
examination performed with a time-optimized contrast bolus in order to
enhance the cerebral venous system [17,41]. The diagnosis of CVT can
be made by evaluation of the axial thin-section contrast-enhanced
source images of a helical CT scan. However, two- and three-dimen-
sional (2D and 3D) reformation techniques (e.g. maximum intensity
projection, integral display, and volume rendering) can be used to
provide detailed anatomic images of the deep and superficial cerebral
veins free from overprojecting bones and brain parenchyma [17,42].
On CT venography, a thrombosed cerebral vein can be visualized as a
filling defect (Fig. 1B) [5,9]. Also indirect signs of CVT such as brain
edema and subarachnoid haemorrhage can contribute to the diagnosis
of CVT [2,5].
In the most relevant studies available, CT venography was found to
be a reliable alternative to DSA for diagnosing CVT [40,43,44] with a
sensitivity and specificity of both 100% (Appendix 3) [43]. However,
quality of this evidence is low, since individual studies included<100
patients, were observational and suffered from a high risk of bias [40].
Other studies used consensus reading of multiple imaging mod-
alities and final clinical outcome as reference standard rather than DSA
(Appendix 3) [10,21,45]. In these studies, CT venography was found to
be accurate for diagnosing cerebral sinus thrombosis as well, with a
sensitivity of 100% (95%CI 88–100%) and specificity of 100% (95%CI
95–100%) [10,21,45]. However, these studies were also small
(n < 34) and retrospective. Notably, CT venography has been shown
to be of limited diagnostic value for diagnosing cortical vein thrombosis
with a reported sensitivity of 6–75% [21,45]. This is explained by the
fact that the ‘missing vein’, i.e. contrast filling defect, is difficult to
distinguish from physiological variations in venous anatomy [21].
Thus, available literature supports the use of CT venography for
diagnosing cerebral sinus thrombosis, but less so for cortical vein
thrombosis [21].
4. Emerging CT techniques
In past years new CT techniques have been developed that may
allow better diagnosis of CVT. With the emerge of multidetector row CT
(MDCT), thin slices are obtained with the use of less contrast and
shorter scanning time allowing better image quality without sig-
nificantly increasing overall radiation dose [45,46]. Currently 320-
MDCT techniques are used that may acquire brain volumes within a
single second.
Several techniques can be used for removing unwanted overlying
(bone) structures from the vascular (venous) structures to improve the
diagnostic accuracy of CT venography, which is especially needed for
3D interpretation. Previous studies have used the ‘graded subtraction’
B.A.
Fig. 1. Axial CT images of a patient with acute sinus thrombosis; A. Non-contrast CT image shows a hyperdense aspect of both transverse sinus (arrows) and B. CT




Non-contrast-enhanced flow related MRI Gradient echo: 2D TOF MRV, 3D TOF MRV, 2D PC MRV, 3D PC MRV
Native contrast thrombus MRI Spin echo: T1-WI FSE/TSE, T2-WI FSE/TSE, FLAIR, PDw, MR Black Blood Imaging (MRBTI: T1-WI 3D SPACE), 3DT1 TSE SPAIR
Gradient echo: DWI, MR Direct Thrombus Imaging (MRDTI: T1-WI magnetization prepared 3D gradient TFE)
Gradient echo susceptibility weighted: T2*WI, T2*WI SE EPI, T2*SW, T2*GRE, GRE
Contrast-enhanced (T1 SE or GRE) MRI Spin echo: CE T1-WI SE/FSE
Gradient echo: 3D T1 GRE/MP-RAGE, CE T1 GRE, CE MRV (including combo 4D MRV, 3D EC MRV, CE TOF MRV)
Note: MRI: magnetic resonance imaging, D TOF MRV: dimensional time-of-flight magnetic resonance venography, PC MRV: phase-contrast magnetic resonance
venography, T1/T2-WI: T1/T2-weighted imaging, FSE: fast spin-echo, TSE: turbo spin-echo, FLAIR: Fluid Attenuated Inversion Recovery, PDw: proton density
weighted, SPACE: variable-flip-angle-turbo spin echo, SPAIR: Spectral Attenuated Inversion Recovery DWI: diffusion weighted imaging, TFE: turbo field echo, SE:
spin-echo, EPI: echo-planar imaging, SW: susceptibility weighted, GRE: gradient-echo, CE: contrast-enhanced, MP-RAGE: magnetization-prepared rapid gradient-
echo.
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technique, a non-automated post-processing technique which is time-
consuming and operator dependent [41,42,47]. State of the art tech-
niques include mask-subtraction and dual-energy. With mask-subtrac-
tion a low-dose non-enhanced CT is subtracted from the contrast-en-
hanced vascular (CT venography) acquisition [47,48]. With dual-
energy techniques bone removal is obtained by postprocessing a dual-
energy CT data set that is simultaneously acquired with a low- and a
high kilovoltage, where difference in x-ray absorption of different ma-
terials depend on x-ray energy [49]. New spectral CT techniques such as
photon-counting CT hold promise for further improved visualization of
CVT [50,51].
5. Magnetic resonance imaging
Various MR techniques are available to visualize cerebral vascular
structures and/or thrombosis. The MRI techniques can be divided into
three groups based on how the thrombosis is depicted; 1) non-contrast-
enhanced flow related MRI, 2) native contrast thrombus MRI and 3)
contrast-enhanced MRI (Table 2). Non-contrast-enhanced flow related
MRI, often called non-contrast-enhanced magnetic resonance veno-
graphy (MRV), includes time-of-flight (TOF) MRV and phase-contrast
(PC) MRV (Table 3). With this MR technique a thrombus can be de-
picted by absence of normal flow patterns (Fig. 2). A thrombus can also
be directly visualized with native contrast thrombus MRI techniques.
These sequences are used to visualize thrombus by presence of para-
magnetic deoxyhaemoglobin, methaemoglobin, or hemosiderin [52].
Moreover, MRI after the administration of an intravenous gadolinium-
based agent can be used (contrast-enhanced MRI), which allows direct
luminal visualization that is comparable to that of CT venography,
where a thrombus can be identified as a filling defect [5]. Compared to
CT venography, MRI is more sensitive for the detection of small par-
enchymal lesions and cerebral edema and has the advantage of not
exposing the patient to ionizing radiation [5,12,53]. On the other hand,
advantages of CT venography over MRI are the fast acquisition times
and the possibility to scan more patients, since many MRI contra-
indications exist.
5.1. Non-contrast-enhanced flow related MRI
Most studies that evaluated the diagnostic accuracy of non-contrast-
enhanced flow related MRI techniques compared to DSA found an
adequate sensitivity and specificity for CVT (Appendix 4) [13,54–57].
Two studies evaluating non-contrast-enhanced PC MRV found that this
technique is sensitive for diagnosing CVT with a sensitivity of 100% and
specificity of 71% [13,56]. Notably, DSA was not performed in all study
participants [13,56]. The non-contrast-enhanced TOF MRV technique
also seems highly reliable for CVT in larger cerebral veins and sinuses.
However, this technique was not sensitive for assessing smaller veins
(i.e. in branches of cortical veins) [55,57,58].
Most studies evaluated the diagnostic accuracy of non-contrast-en-
hanced flow related MRI techniques compared to the combination of
multiple imaging modalities and final clinical outcome or contrast-en-
hanced MRV (Appendix 5) [21,32,59–68], were adequate sensitivity
and specificity for CVT were found too. Non-contrast-enhanced TOF
MRV and PC MRV had a sensitivity of 64–100% and 48–100%, re-
spectively, although with wide 95% confidence intervals. Moreover,
non-contrast-enhanced flow related MRI was confirmed to be less ac-
curate for identifying cortical vein thrombosis [21,64].
5.2. Native contrast thrombus MRI
With native contrast thrombus MRI techniques, a thrombus is di-
rectly visualized (Fig. 3). In the first 5 days after clot formation, the
signal may be isointense on T1-weighted images (T1WI) and hy-
pointense on T2-weighted images (T2WI) as the acute thrombus has a
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15 days, the clot may appear hyperintense on T1WI and T2WI due to a
high methaemoglobin concentration [2,5]. After 15 days the thrombus
may appear iso to hyperintense on T2WI and isointense on T1WI [2,5].
On gradient-recalled echo (GRE) susceptibility weighted (SW) images,
deposited blood breakdown products (i.e. methaemoglobin, deox-
yhaemoglobin) can cause exaggerated signal drop-out (Fig. 4) so that
intraluminal thrombi can be depicted in stages where the clot may be
subtle in other sequences [5].
The combination of different native contrast thrombus MRI tech-
niques had an overall sensitivity and specificity of 84–97% and
28–96%, respectively, for the diagnosis of CVT (Appendices 4 and 5)
[32,56,61,69,70[91,92][93–95]. The comparison of these studies and
interpretation of their results is complicated by the inclusion of het-
erogeneous patient populations and different applied MRI sequences,
e.g., T1WI, T2WI, fluid-attenuated inversion recovery (FLAIR), diffu-
sion weighted imaging (DWI) and proton density weighted (PDw)
sequences. For the diagnosis of cortical vein thrombosis however, GRE
SW MRI was consistently reported to have an adequate sensitivity of
97–98% and specificity of 100% [21,71,72].
5.3. Contrast-enhanced MRI
When DSA was used as reference standard, contrast-enhanced MRI
was more accurate for diagnosing cerebral sinus thrombosis than non-
contrast-enhanced flow related and native contrast thrombus MR se-
quences, with a sensitivity and specificity of 83% and 100% versus
8–51% and 80–93%, respectively (Appendix 4) [55]. Other studies used
the combination of multiple imaging modalities and final clinical out-
come [61–63] or contrast-enhanced MRV [70] alone as reference (Ap-
pendix 5). In these latter studies, contrast-enhanced MRI was also more
sensitive for CVT than non-contrast-enhanced MRI, with a sensitivity
and specificity of 86–97% and 52–100% versus 55–97% and 28–95%,
A. B.
Fig. 2. Coronal Phase Contrast (PC) MR venography (MRV) image of a patient with acute sinus thrombosis of the left transverse and sigmoid sinus; A. Coronal PC
MRV image and B. PC MRV maximum intensity projection (MIP) with absence of flow in the left transverse and sigmoid sinus (arrows).
A. B.
Fig. 3. Coronal 3DT1 TSE SPAIR images: A. with a high signal intensity of the left transverse sinus (arrows) in a patient with acute sinus thrombosis (6–15 days old)
and B. with high signal intensity in two cortical veins (arrows) in another patient indicative of acute cortical vein thrombosis (6–15 days old).
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respectively [61–63,70]. Furthermore, in studies that evaluated the
diagnostic accuracy of MRI for visualization of cerebral veins (not ne-
cessarily in the setting of suspected CVT), contrast-enhanced MRI was
found to be superior to non-contrast-enhanced MRI as well [66,73–78].
In a recent meta-analysis the diagnostic accuracy of flow related
MRI (MRV; contrast- and non-contrast-enhanced) for CVT was sum-
marized [79]. Subgroup analyses of different MRV techniques con-
firmed that the diagnostic performance of contrast-enhanced MRV was
better than that of non-contrast-enhanced TOF and PC MRV.
6. Magnetic resonance black-blood thrombus imaging
Recently, magnetic resonance black-blood thrombus imaging
(MRBTI), a native contrast thrombus MR technique, has been evaluated
in the setting of suspected CVT [14,80,81]. MRBTI yielded a sensitivity
of 100% and specificity of 96%, even up to the level of individual ve-
nous segments, using CT and MRI in combination with clinical and
outcome assessments -but not DSA- as diagnostic standard [80]. A very
similar native contrast thrombus MR technique, MR Direct Thrombus
Imaging (MRDTI), has been shown to be highly accurate for the diag-
nosis of deep vein thrombosis and for the differentiation of acute versus
chronic deep vein thrombosis in the legs [82–87]. Thus, this technique
may be of great value for diagnosing CVT as well, especially in complex
cases such as in suspected recurrent CVT. Further research is however
needed before MRBTI can be used for the diagnosis of CVT in daily
clinical practice.
7. MRI versus CT venography
When CT venography was compared to MRI, CT venography had a
sensitivity of 100% and specificity of 100% for the diagnosis of cerebral
sinus thrombosis (Appendix 6) [41,88,89]. Two of these studies even
found that CT venography was better for the evaluation of small vessel
anatomy with fewer artefacts than MRI [41,88]. It is important to note
that these studies were small (n = 24–36), included patients with
suspected CVT but also patients without the suspicion for CVT (follow-
up after acute CVT or pre-operative screening), and did not perform the
same MR sequences in all included patients.
8. Conclusion
Contrast-enhanced MRI is more accurate than non-contrast-en-
hanced MRI for diagnosing CVT, as CT venography is more accurate
than CT. Both CT venography and contrast-enhanced MRI seem ade-
quate for establishing a CVT diagnosis. Solid evidence to choose one
over the other is however unavailable. In practice therefore, clinical
availability, local preference and experience mainly determine which
modality is used. Large high-quality diagnostic studies are needed to
improve clinical care and standardize clinical trials.
Acknowledgment
We thank Joost Doornbos for his help in classifying the different
MRI techniques.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.thromres.2020.03.011.
References
[1] F. Dentali, M. Gianni, M.A. Crowther, W. Ageno, Natural history of cerebral vein
thrombosis: a systematic review, Blood. 108 (4) (2006) 1129–1134.
[2] G. Saposnik, F. Barinagarrementeria, R.D. Brown Jr.et al., Diagnosis and manage-
ment of cerebral venous thrombosis: a statement for healthcare professionals from
the American Heart Association/American Stroke Association, Stroke. 42 (4) (2011)
1158–1192.
[3] J.M. Coutinho, S.M. Zuurbier, M. Aramideh, J. Stam, The incidence of cerebral
venous thrombosis: a cross-sectional study, Stroke. 43 (12) (2012) 3375–3377.
[4] N. Riva, W. Ageno, Clinical manifestations and imaging tools in the diagnosis of
splanchnic and cerebral vein thromboses, Thromb Res. 163 (2017) 252–259.
[5] A.A. Dmytriw, J.S.A. Song, E. Yu, C.S. Poon, Cerebral venous thrombosis: state of
the art diagnosis and management, Neuroradiology. 60 (7) (2018) 669–685.
[6] F. Masuhr, S. Mehraein, K. Einhaupl, Cerebral venous and sinus thrombosis, J
Neurol. 251 (1) (2004) 11–23.
[7] R.A. Willinsky, S.M. Taylor, K. TerBrugge, R.I. Farb, G. Tomlinson, W. Montanera,
Neurologic complications of cerebral angiography: prospective analysis of 2,899
procedures and review of the literature, Radiology. 227 (2) (2003) 522–528.
[8] R. Agid, I. Shelef, J.N. Scott, R.I. Farb, Imaging of the intracranial venous system,
Neurologist. 14 (1) (2008) 12–22.
[9] C.S. Poon, J.K. Chang, A. Swarnkar, M.H. Johnson, J. Wasenko, Radiologic diag-
nosis of cerebral venous thrombosis: pictorial review, AJR Am J Roentgenol. 189 (6
A. B.
Fig. 4. Transversal native contrast thrombus MR images of a patient with left temporal cortical vein thrombosis with venous haemorrhagic infarction: A. T2 weighted
image showing a region of increased signal intensity in the cortex and subcortical white matter in the left temporal lobe and B. Susceptibility weighted image showing
multiple susceptibility artefacts indicating haemorrhagic transformation in the pathological region with pronounced blooming artefacts within the thrombosed
cortical veins (arrow).
L.F. van Dam, et al. Thrombosis Research 189 (2020) 132–139
137
Suppl) (2007) S64–S75.
[10] J. Linn, B. Ertl-Wagner, K.C. Seelos, et al., Diagnostic value of multidetector-row CT
angiography in the evaluation of thrombosis of the cerebral venous sinuses, AJNR
Am J Neuroradiol. 28 (5) (2007) 946–952.
[11] J.L. Leach, R.B. Fortuna, B.V. Jones, M.F. Gaskill-Shipley, Imaging of cerebral ve-
nous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls,
Radiographics 26 (Suppl. 1) (2006) S19–S41 (discussion S42-13).
[12] J.M. Coutinho, Cerebral venous thrombosis, Journal of Thrombosis and
Haemostasis. 906 (2015) 183–193.
[13] K. Ozturk, E. Soylu, M. Parlak, Dural venous sinus thrombosis: the combination of
noncontrast CT, MRI and PC-MR venography to enhance accuracy, Neuroradiol J.
31 (2018) 473–481 (1971400918781969).
[14] J.M. Ferro, P. Canhao, D. Aguiar de Sousa, Cerebral venous thrombosis, Presse Med.
45 (12 Pt 2) (2016) e429–e450.
[15] P.J. Buyck, F. De Keyzer, D. Vanneste, G. Wilms, V. Thijs, P. Demaerel, CT density
measurement and H:H ratio are useful in diagnosing acute cerebral venous sinus
thrombosis, AJNR Am J Neuroradiol. 34 (8) (2013) 1568–1572.
[16] K.A. Herrmann, B. Sporer, T.A. Yousry, Thrombosis of the internal cerebral vein
associated with transient unilateral thalamic edema: a case report and review of the
literature, AJNR Am J Neuroradiol. 25 (8) (2004) 1351–1355.
[17] M.H. Rodallec, A. Krainik, A. Feydy, et al., Cerebral venous thrombosis and mul-
tidetector CT angiography: tips and tricks, Radiographics (26 Suppl 1) (2006)
S5–18 (discussion S42-13).
[18] J.M. Coutinho, R. van den Berg, S.M. Zuurbier, et al., Small juxtacortical hemor-
rhages in cerebral venous thrombosis, Ann Neurol. 75 (6) (2014) 908–916.
[19] S.C. Crawford, K.B. Digre, C.A. Palmer, D.A. Bell, A.G. Osborn, Thrombosis of the
deep venous drainage of the brain in adults. Analysis of seven cases with review of
the literature, Arch Neurol. 52 (11) (1995) 1101–1108.
[20] J. Linn, T. Pfefferkorn, K. Ivanicova, et al., Noncontrast CT in deep cerebral venous
thrombosis and sinus thrombosis: comparison of its diagnostic value for both en-
tities, AJNR Am J Neuroradiol. 30 (4) (2009) 728–735.
[21] J. Linn, S. Michl, B. Katja, et al., Cortical vein thrombosis: the diagnostic value of
different imaging modalities, Neuroradiology. 52 (10) (2010) 899–911.
[22] T. Roland, J. Jacobs, A. Rappaport, R. Vanheste, G. Wilms, P. Demaerel,
Unenhanced brain CT is useful to decide on further imaging in suspected venous
sinus thrombosis, Clin Radiol. 65 (1) (2010) 34–39.
[23] M. Garetier, J. Rousset, E. Pearson, et al., Value of spontaneous hyperdensity of
cerebral venous thrombosis on helical CT, Acta Radiol. 55 (10) (2014) 1245–1252.
[24] J. Avsenik, J.P. Oblak, K.S. Popovic, Non-contrast computed tomography in the
diagnosis of cerebral venous sinus thrombosis, Radiol Oncol. 50 (3) (2016)
263–268.
[25] S. Zaheer, D. Iancu, N. Seppala, et al., Quantitative non-contrast measurements
improve diagnosing dural venous sinus thrombosis, Neuroradiology. 58 (7) (2016)
657–663.
[26] P.J. Buyck, S.M. Zuurbier, C. Garcia-Esperon, et al., Diagnostic accuracy of non-
contrast CT imaging markers in cerebral venous thrombosis, Neurology. 92 (8)
(2019) e841–e851.
[27] D.F. Black, A.E. Rad, L.A. Gray, N.G. Campeau, D.F. Kallmes, Cerebral venous sinus
density on noncontrast CT correlates with hematocrit, AJNR Am J Neuroradiol. 32
(7) (2011) 1354–1357.
[28] A. Alsafi, A. Lakhani, L. Carlton Jones, K. Lobotesis, Cerebral venous sinus throm-
bosis, a nonenhanced CT diagnosis? Radiol Res Pract. 2015 (2015) 581437.
[29] D.A. Besachio, E.P. Quigley, L.M. Shah, K.L. Salzman, Noncontrast computed to-
mographic Hounsfield unit evaluation of cerebral venous thrombosis: a quantitative
evaluation, Neuroradiology. 55 (8) (2013) 941–945.
[30] P. Digge, K. Prakashini, K.V. Bharath, Plain CT vs MR venography in acute cerebral
venous sinus thrombosis: triumphant dark horse, Indian J Radiol Imaging. 28 (3)
(2018) 280–284.
[31] A. Shayganfar, R. Azad, M. Taki, Are cerebral veins hounsfield unit and H: H ratio
calculating in unenhanced CT eligible to diagnosis of acute cerebral vein throm-
bosis? J Res Med Sci. 24 (2019) 83.
[32] L. Rizzo, Cerebral venous thrombosis: role of CT, MRI and MRA in the emergency
setting, Neuroradiology. 115 (2010) 313–325.
[33] P.H. Tang, J. Chai, Y.H. Chan, S.M. Chng, C.C. Lim, Superior sagittal sinus
thrombosis: subtle signs on neuroimaging, Ann Acad Med Singapore. 37 (5) (2008)
397–401.
[34] S. Appenzeller, C.B. Zeller, J.M. Annichino-Bizzachi, et al., Cerebral venous
thrombosis: influence of risk factors and imaging findings on prognosis, Clin Neurol
Neurosurg. 107 (5) (2005) 371–378.
[35] Z. Zhang, J. Long, W. Li, Cerebral venous sinus thrombosis: a clinical study of 23
cases, Chin Med J (Engl). 113 (11) (2000) 1043–1045.
[36] F. Lafitte, M. Boukobza, J.P. Guichard, D. Reizine, F. Woimant, J.J. Merland, Deep
cerebral venous thrombosis: imaging in eight cases, Neuroradiology. 41 (6) (1999)
410–418.
[37] K.C. Rao, H.C. Knipp, E.J. Wagner, Computed tomographic findings in cerebral
sinus and venous thrombosis, Radiology. 140 (2) (1981) 391–398.
[38] J.M. Ferro, P. Canhao, Cerebral venous sinus thrombosis: update on diagnosis and
management, Curr Cardiol Rep. 16 (9) (2014) 523.
[39] W. Xu, L. Gao, T. Li, N.D. Ramdoyal, J. Zhang, A. Shao, The performance of CT
versus MRI in the differential diagnosis of cerebral venous thrombosis, Thromb
Haemost. 118 (6) (2018) 1067–1077.
[40] J.M. Ferro, M.G. Bousser, P. Canhao, et al., European Stroke Organization guideline
for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the
European Academy of Neurology, Eur J Neurol. 24 (10) (2017) 1203–1213.
[41] S.O. Casey, R.A. Alberico, M. Patel, et al., Cerebral CT venography, Radiology. 198
(1) (1996) 163–170.
[42] C.B. Majoie, M. van Straten, H.W. Venema, G.J. den Heeten, Multisection CT ve-
nography of the dural sinuses and cerebral veins by using matched mask bone
elimination, AJNR Am J Neuroradiol. 25 (5) (2004) 787–791.
[43] S.G. Wetzel, E. Kirsch, K.W. Stock, M. Kolbe, A. Kaim, E.W. Radue, Cerebral veins:
comparative study of CT venography with intraarterial digital subtraction angio-
graphy, AJNR Am J Neuroradiol. 20 (2) (1999) 249–255.
[44] G.K. Wong, D.Y. Siu, J.M. Abrigo, et al., Computed tomographic angiography and
venography for young or nonhypertensive patients with acute spontaneous in-
tracerebral hemorrhage, Stroke. 42 (1) (2011) 211–213.
[45] A.B. Gaikwad, B.A. Mudalgi, K.B. Patankar, J.K. Patil, D.V. Ghongade, Diagnostic
role of 64-slice multidetector row CT scan and CT venogram in cases of cerebral
venous thrombosis, Emerg Radiol. 15 (5) (2008) 325–333.
[46] H.U.P. Alsleem, K.S. Mong, R. Davidson, Effects of radiographic techniques on the
low-contrast detail detectability performance of digital radiography systems, Radiol
Technol. 85 (6) (2014) 614–622.
[47] H.A. Gratama van Andel, L.J. van Boven, M.A. van Walderveen, et al., Interobserver
variability in the detection of cerebral venous thrombosis using CT venography with
matched mask bone elimination, Clin Neurol Neurosurg. 111 (9) (2009) 717–723.
[48] M. Romijn, H.A. Gratama van Andel, M.A. van Walderveen, et al., Diagnostic ac-
curacy of CT angiography with matched mask bone elimination for detection of
intracranial aneurysms: comparison with digital subtraction angiography and 3D
rotational angiography, AJNR Am J Neuroradiol. 29 (1) (2008) 134–139.
[49] H. Seo, D.S. Choi, H.S. Shin, J.M. Cho, E.H. Koh, S. Son, Bone subtraction 3D CT
venography for the evaluation of cerebral veins and venous sinuses: imaging
techniques, normal variations, and pathologic findings, AJR Am J Roentgenol. 202
(2) (2014) W169–W175.
[50] M.J. Willemink, M. Persson, A. Pourmorteza, N.J. Pelc, D. Fleischmann, Photon-
counting CT: technical principles and clinical prospects, Radiology. 289 (2) (2018)
293–312.
[51] R. Symons, D.S. Reich, M. Bagheri, et al., Photon-counting computed tomography
for vascular imaging of the head and neck: first in vivo human results, Invest Radiol.
53 (3) (2018) 135–142.
[52] G.B. Chavhan, P.S. Babyn, B. Thomas, M.M. Shroff, E.M. Haacke, Principles, tech-
niques, and applications of T2*-based MR imaging and its special applications,
Radiographics. 29 (5) (2009) 1433–1449.
[53] R. Behrouzi, M. Punter, Diagnosis and management of cerebral venous thrombosis,
Clin Med (Lond). 18 (1) (2018) 75–79.
[54] Y.K. Ihn, W.S. Jung, S.S. Hwang, The value of T2*-weighted gradient-echo MRI for
the diagnosis of cerebral venous sinus thrombosis, Clin Imaging. 37 (3) (2013)
446–450.
[55] L. Liang, Y. Korogi, T. Sugahara, et al., Evaluation of the intracranial dural sinuses
with a 3D contrast-enhanced MP-RAGE sequence: prospective comparison with 2D-
TOF MR venography and digital subtraction angiography, AJNR Am J Neuroradiol.
22 (3) (2001) 481–492.
[56] F. Lafitte, M. Boukobza, J.P. Guichard, et al., MRI and MRA for diagnosis and
follow-up of cerebral venous thrombosis (CVT), Clin Radiol. 52 (9) (1997) 672–679.
[57] T.J. Vogl, C. Bergman, A. Villringer, K. Einhaupl, J. Lissner, R. Felix, Dural sinus
thrombosis: value of venous MR angiography for diagnosis and follow-up, AJR Am J
Roentgenol. 162 (5) (1994) 1191–1198.
[58] H.P. Mattle, K.U. Wentz, R.R. Edelman, et al., Cerebral venography with MR,
Radiology. 178 (2) (1991) 453–458.
[59] D. Renard, E. Le Bars, C. Arquizan, N. Gaillard, N.M. de Champfleur, I. Mourand,
Time-of-flight MR angiography in cerebral venous sinus thrombosis, Acta Neurol
Belg. 117 (4) (2017) 837–840.
[60] R. Jalli, F. Zarei, S. Farahangiz, et al., The sensitivity, specificity, and accuracy of
contrast-enhanced T1-weighted image, T2*-weighted image, and magnetic re-
sonance venography in diagnosis of cerebral venous sinus thrombosis, J Stroke
Cerebrovasc Dis. 25 (8) (2016) 2083–2086.
[61] S. Sari, S. Verim, S. Hamcan, et al., MRI diagnosis of dural sinus - cortical venous
thrombosis: immediate post-contrast 3D GRE T1-weighted imaging versus un-
enhanced MR venography and conventional MR sequences, Clin Neurol Neurosurg.
134 (2015) 44–54.
[62] S. Meckel, C. Reisinger, J. Bremerich, et al., Cerebral venous thrombosis: diagnostic
accuracy of combined, dynamic and static, contrast-enhanced 4D MR venography,
AJNR Am J Neuroradiol. 31 (3) (2010) 527–535.
[63] R. Klingebiel, H.C. Bauknecht, G. Bohner, R. Kirsch, J. Berger, F. Masuhr,
Comparative evaluation of 2D time-of-flight and 3D elliptic centric contrast-en-
hanced MR venography in patients with presumptive cerebral venous and sinus
thrombosis, Eur J Neurol. 14 (2) (2007) 139–143.
[64] F.A. Fellner, C. Fellner, F.T. Aichner, G. Molzer, Importance of T2*-weighted gra-
dient-echo MRI for diagnosis of cortical vein thrombosis, Eur J Radiol. 56 (2)
(2005) 235–239.
[65] K.O. Lovblad, J. Schneider, C. Bassetti, et al., Fast contrast-enhanced MR whole-
brain venography, Neuroradiology. 44 (8) (2002) 681–688.
[66] J.H. Fu, P.H. Lai, C.C. Hsiao, et al., Comparison of real-time three-dimensional
gadolinium-enhanced elliptic centric-ordered MR venography and two-dimensional
time-of-flight MR venography of the intracranial venous system, J Chin Med Assoc.
73 (3) (2010) 131–138.
[67] J. Bracken, A. Barnacle, M. Ditchfield, Potential pitfalls in imaging of paediatric
cerebral sinovenous thrombosis, Pediatr Radiol. 43 (2) (2013) 219–231.
[68] J.S. Ho, Cerebral venous sinus thrombosis: comparison of multidetector computed
tomography venogram (MDCTV) and magnetic resonance venography (MRV) of
various field strengths, Neurology Asia. 17 (4) (2012) 281–291.
[69] K. Ozturk, E. Soylu, M. Parlak, Dural venous sinus thrombosis: the combination of
noncontrast CT, MRI and PC-MR venography to enhance accuracy, Neuroradiol J.
31 (5) (2018) 473–481.
L.F. van Dam, et al. Thrombosis Research 189 (2020) 132–139
138
[70] G. Sadigh, M.E. Mullins, A.M. Saindane, Diagnostic performance of MRI sequences
for evaluation of dural venous sinus thrombosis, AJR Am J Roentgenol. 206 (6)
(2016) 1298–1306.
[71] N. Altinkaya, S. Demir, O. Alkan, M. Tan, Diagnostic value of T2*-weighted gra-
dient-echo MRI for segmental evaluation in cerebral venous sinus thrombosis, Clin
Imaging. 39 (1) (2015) 15–19.
[72] A. Idbaih, M. Boukobza, I. Crassard, R. Porcher, M.G. Bousser, H. Chabriat, MRI of
clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted
images, Stroke. 37 (4) (2006) 991–995.
[73] R.I. Farb, J.N. Scott, R.A. Willinsky, W.J. Montanera, G.A. Wright, K.G. ter Brugge,
Intracranial venous system: gadolinium-enhanced three-dimensional MR veno-
graphy with auto-triggered elliptic centric-ordered sequence–initial experience,
Radiology. 226 (1) (2003) 203–209.
[74] N. Rollins, C. Ison, T. Reyes, J. Chia, Cerebral MR venography in children: com-
parison of 2D time-of-flight and gadolinium-enhanced 3D gradient-echo techniques,
Radiology. 235 (3) (2005) 1011–1017.
[75] S.G. Wetzel, M. Law, V.S. Lee, S. Cha, G. Johnson, K. Nelson, Imaging of the in-
tracranial venous system with a contrast-enhanced volumetric interpolated ex-
amination, Eur Radiol. 13 (5) (2003) 1010–1018.
[76] K. Kirchhof, T. Welzel, O. Jansen, K. Sartor, More reliable noninvasive visualization
of the cerebral veins and dural sinuses: comparison of three MR angiographic
techniques, Radiology. 224 (3) (2002) 804–810.
[77] M. Lettau, M. Laible, R.J. Barrows, S. Heiland, M. Bendszus, S. Hahnel, 3-T contrast-
enhanced MR angiography with parallel imaging in cerebral venous and sinus
thrombosis, AM J Neuroradiol. 38 (5) (2011) 275–282.
[78] A. Haroun, Utility of contrast-enhanced 3D turbo-flash MR angiography in evalu-
ating the intracranial venous system, Neuroradiology. 47 (5) (2005) 322–327.
[79] L. Gao, W. Xu, T. Li, et al., Accuracy of magnetic resonance venography in diag-
nosing cerebral venous sinus thrombosis, Thromb Res. 167 (2018) 64–73.
[80] Q. Yang, J. Duan, Z. Fan, et al., Early detection and quantification of cerebral ve-
nous thrombosis by magnetic resonance black blood thrombus imaging (MRBTI),
Stroke. 47 (2) (2016) 404–409.
[81] P.P. Niu, Y. Yu, Z.N. Guo, et al., Diagnosis of non-acute cerebral venous thrombosis
with 3D T1-weighted black blood sequence at 3T, J Neurol Sci. 367 (2016) 46–50.
[82] M. Tan, G.C. Mol, C.J. van Rooden, et al., Magnetic resonance direct thrombus
imaging differentiates acute recurrent ipsilateral deep vein thrombosis from re-
sidual thrombosis, Blood. 124 (4) (2014) 623–627.
[83] P. Saha, M.E. Andia, B. Modarai, et al., Magnetic resonance T1 relaxation time of
venous thrombus is determined by iron processing and predicts susceptibility to
lysis, Circulation. 128 (7) (2013) 729–736.
[84] D.G. Fraser, A.R. Moody, P.S. Morgan, A.L. Martel, I. Davidson, Diagnosis of lower-
limb deep venous thrombosis: a prospective blinded study of magnetic resonance
direct thrombus imaging, Ann Intern Med. 136 (2) (2002) 89–98.
[85] F.A. Klok, M. Tan, M.V. Huisman, Letter by Klok et al regarding article, “18F-
fluorodeoxyglucose positron emission tomography/computed tomography enables
the detection of recurrent same-site deep vein thrombosis by illuminating recently
formed, neutrophil-rich thrombus”, Circulation. 131 (24) (2015) e530.
[86] L.F. van Dam, C.E.A. Dronkers, G. Gautam, et al., Diagnosis of suspected recurrent
ipsilateral deep vein thrombosis with magnetic resonance direct thrombus imaging,
Blood (2020) (Epub ahead of print).
[87] R.E. Westerbeek, C.J. Van Rooden, M. Tan, et al., Magnetic resonance direct
thrombus imaging of the evolution of acute deep vein thrombosis of the leg, J
Thromb Haemost. 6 (7) (2008) 1087–1092.
[88] R.R. Ozsvath, S.O. Casey, E.S. Lustrin, R.A. Alberico, A. Hassankhani, M. Patel,
Cerebral venography: comparison of CT and MR projection venography, AJR Am J
Roentgenol. 169 (6) (1997) 1699–1707.
[89] N. Khandelwal, A. Agarwal, R. Kochhar, et al., Comparison of CT venography with
MR venography in cerebral sinovenous thrombosis, AJR Am J Roentgenol. 187 (6)
(2006) 1637–1643.
[90] C.K. Onyambu, E. Amayo, J.M. Kitonyi, Clinical features and patterns of imaging in
cerebral venous sinus thrombosis at Kenyatta Nationa Hospital, East Afr Med J. 90
(9) (2013) 297–304.
[91] D. Patel, M. Machnowska, S. Symons, et al., Diagnostic performance of routine
brain MRI sequences for dural venous sinus thrombosis, AJNR Am J Neuroradiol. 37
(11) (2016) 2026–2032.
[92] F. Bidar, F. Faeghi, A. Ghorbani, Assessment of cerebral venous sinus thrombosis
using T2 (*)-weighted gradient echo magnetic resonance imaging sequences, Iran J
Neurol. 15 (2) (2016) 96–99.
[93] M.E. Yildiz, U.A. Ozcan, A. Turk, O.S. Ulus, C. Erzen, A. Dincer, Diffusion-weighted
MR imaging findings of cortical vein thrombosis at 3 T, Clin Neuroradiol. 25 (3)
(2015) 249–256.
[94] A.M. Saindane, B.C. Mitchell, J. Kang, N.K. Desai, S. Dehkharghani, Performance of
spin-echo and gradient-echo T1-weighted sequences for evaluation of dural venous
sinus thrombosis and stenosis, AJR Am J Roentgenol. 201 (1) (2013) 162–169.
[95] M. Selim, J. Fink, I. Linfante, S. Kumar, G. Schlaug, L.R. Caplan, Diagnosis of cer-
ebral venous thrombosis with echo-planar T2*-weighted magnetic resonance ima-
ging, Arch Neurol. 59 (6) (2002) 1021–1026.
L.F. van Dam, et al. Thrombosis Research 189 (2020) 132–139
139
